HomeTagsBridge Biotherapeutics

Bridge Biotherapeutics

Biotechnology

Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study

PR Newswire - August 16, 2022

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing novel drugs for cancer, fibrosis and inflammation, announced it has received notice from the...

Biotechnology

Bridge Biotherapeutics to Present Interim Clinical Data from Ongoing Phase 1 Study of BBT-176

PR Newswire - July 13, 2022

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, announced that interim clinical data...